CAREFUSION ANNOUNCES 510(k) CLEARANCE FOR NEW TAKE-APART LAPAROSCOPIC SCISSORS

[at noodls] – SAN DIEGO, Nov. 1, 2012 – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced it recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) … more

View todays social media effects on CFN

View the latest stocks trending across Twitter. Click to view dashboard